Publication:
TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species

dc.contributor.authorRoca Soler, Francisco José
dc.contributor.authorRamakrishnan, Lalita
dc.contributor.departmentBioquímica y Biología Molecular B e Inmunología
dc.date.accessioned2026-02-25T16:21:03Z
dc.date.available2026-02-25T16:21:03Z
dc.date.copyright© 2013 Elsevier Inc.
dc.date.issued2013-04-11
dc.description.abstractTumor necrosis factor (TNF) constitutes a critical host defense against tuberculosis, but its excess is also implicated in tuberculosis pathogenesis in zebrafish and humans. Using the zebrafish, we elucidate the pathways by which TNF mediates tuberculosis pathogenesis. TNF excess induces mitochondrial reactive oxygen species (ROS) in infected macrophages through RIP1-RIP3-dependent pathways. While initially increasing macrophage microbicidal activity, ROS rapidly induce programmed necrosis (necroptosis) and release mycobacteria into the growth-permissive extracellular milieu. TNF-induced necroptosis occurs through two pathways: modulation of mitochondrial cyclophilin D, implicated in mitochondrial permeability transition pore formation, and acid sphingomyelinase-mediated ceramide production. Combined genetic blockade of cyclophilin D and acid sphingomyelinase renders the high TNF state hyperresistant by preventing macrophage necrosis while preserving increased microbicidal activity. Similarly, the cyclophilin D-inhibiting drug alisporivir and the acid sphingomyelinase-inactivating drug, desipramine, synergize to reverse susceptibility, suggesting the therapeutic potential of these orally active drugs against tuberculosis and possibly other TNF-mediated diseases.
dc.formatapplication/pdf
dc.format.extent14
dc.identifier.citationCell 153, 521–534, April 25, 2013
dc.identifier.doihttps://doi.org/10.1016/j.cell.2013.03.022
dc.identifier.eissn1097-4172
dc.identifier.issn0092-8674
dc.identifier.urihttp://hdl.handle.net/10201/213581
dc.languageeng
dc.publisherCell Press
dc.relationFunded by grants from the NIH and the NWRCE for Biodefense and Emerging Infectious Diseases Research (L.R.), and a postdoctoral fellowship from the educational ministry of Spain (F.J.R). L.R. is a recipient of the NIH Director’s Pioneer Award
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0092867413003449
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccess
dc.subject.odsObjetivo 3: Salud
dc.titleTNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublicationes
relation.isAuthorOfPublication7f46a88a-1ff4-4f80-948e-7d636b80e75d
relation.isAuthorOfPublication.latestForDiscovery7f46a88a-1ff4-4f80-948e-7d636b80e75d
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Roca 2013_TNF high_Cell.pdf
Size:
2.26 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.37 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections